Biography & Education

I see my role as an educator, discussing each patient's medical problems in detail. I work with the patient to formulate a treatment plan. I would describe my practice style as very "interactive."
Additional Information

Internship: Michael Reese Hospital, IL



1995 – 2003   Medical Director, Swedish Breast Care Center, Swedish Medical Center, Seattle, WA
1994 – Present   Clinical Instructor in Medicine, University of Washington, Seattle, WA
1992 – Present   Medical Oncologist, Swedish Cancer Institute, Seattle, WA



American College of Physicians
Puget Sound Oncology Consortium (PSOC)
American Society of Clinical Oncology (ASCO)
Southwest Oncology Group (SWOG)
King County Medical Society
National Surgical Adjuvant Breast and Bowel Project (NSABP)


Dr. Ellis was voted "Top Doctors" in Seattle Magazine (2013, 2014).

Surveys were mailed to physicians in King, Pierce, Snohomish and Kitsap counties. The survey asked physicians to name the provider they would seek out or recommend to loved ones.

News Release

  • Oncology - Medical
Education Background
Medical School Johns Hopkins School of Medicine
Residency Michael Reese Hospital, IL
Fellowship University of Chicago Medical Center, IL
  • English

Care Locations

1221 Madison Street
Arnold Pavilion, Suite 200
Seattle, WA 98104
True Family Women's Cancer Center
1221 Madison St.
5th Floor
Seattle 98104
Fax 206-991-2378
Accepted Insurances
  • Community Health Plan of Washington
  • DSHS/Medicaid
  • First Health
  • Great West Life (One Health Plan of WA)
  • Health International
  • Indian Health Services
  • Labor & Industries
  • Medicare
  • Pacificare of Washington
  • Private Healthcare Systems
  • Molina
  • Uniform Medical Plan (WA St Health)
  • United HealthCare
  • Aetna (All Product Lines)
  • Holland America Line Westours
  • Molina Healthcare of WA
  • NorthwestOne
  • Premera Blue Cross (All Product Lines)
  • Regence Blue Shield (All Product Lines)
  • StayWell Insurance (Guam)
  • USC Health Services
  • Van Hall Health
  • First Choice Health Network
  • Evercare
  • Humana ChoiceCare Network
  • Multiplan
  • Inc.
  • Interplan Health Group
  • Great West
  • Premier Healthcare Exchange
  • Sterling Life
  • Three Rivers Provider Network
  • Tricare
Accepted Payment Methods
Medicare, Medicaid/DSHS, Bill Insurance, VISA, Master Card, Cash, Check, American Express, Discover Card, Money Order
Accepting Medicaid




Dr. Erin Ellis is the lead investigator for the following clinical trials currently available at the Swedish Cancer Institute:

I-SPY 2 Trial (Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging And moLecular Analysis 2)

A Randomized Phase 2 Study of the Efficacy and Tolerability of Veliparib in Combination with Temozolomide or Veliparib in Combination with Carboplatin and Paclitaxel Versus Placebo Plus Carboplatin and Paclitaxel in Subjects with BRCA1 or BRCA2 Mutation and Metastatic Breast Cancer



WI Bensinger, KS Schiffman, L Holmberg, FR Appelbaum, R Maziarz, P Montgomery, E Elllis, S Rivkin, P Weiden, et al. High-dose busulfan, melphalan, thiotepa, and peripheral blood stem cell infusion for the treatment of metastatic breast cancer. Bone Marrow Transplanation, 1997.

Golom HM and Ellis E. Treatment options for hairy cell leukemia. Seminars in Oncology, 18: 7-11, 1991.

Ellis ED, Williams, SF and Golomb HM. Current advances and guidelines in therapy. In benign and malignant lymphadenopathies: A Guide to Clinical and Laboratory Diagosis, edited by GA Pangalis and A Polliak.

Moormeier JA, Williams SF, Kaminer LS, Ellis ED, Garner M, Farah, Weichselbaum RR, and Bitran JD. Autologous bone marrow transplantation followed by involved field radiotherapy in aptients with relapsed or refractory Hodgkin’s disease. Leukemia and Lymphoma.

Ellis ED, Williams, SF, moormeier JA, Mainer LS, and Bitran JD. A phase I-II study of high dose cyclophosphamide, thiotepa and escalating doses of mitoxantrone with autologous stem cell rescue in patients with refractory malignancies. Bone Marrow Transplatnation, 6: 439-442, 1990.

Ellis ED, Moormeier JA and Golomb HM. The treatment of hairy cell leukemia; a review. Leukemia and Lymphoma, 1: 77-85, 1990.

Le Beau MM, Bitter MA, Larson RA, Doane LA, Ellis ED, Franklin WA, Rubin CM, Kadin ME and Varidman JW. The t(2;5)(p23;q35): A recurring chromosomal abnormality in Ki-1 positive anaplastic large cell lymphoma. Leukemia, 3: 866-870, 1989.


Ellis E, Vokes E, Hoffman P, Krishnasamy S, Gradishar W, English C, Ferguson M, Haraf D, Bitran J and Golomb H. A phase II study of neoadjuvant chemotherapy and concomitant chemoradiotherapy for stage III lung cancer. Proceedings of ASCO, 1991.

Bitran JD, Vokes EE, Hoffman PC, Ellis ED, Gradishar W and Golomb HM. Combines modality therapy for stage III non-small cell lung cancer (NSCLC). Third International Congress on Neoadjuvant Chemotherapy, February 6-9, 1991.

Ellis ED, Williams SF, Moormeier JA, Bitran JD and Ratain MJ. A phase I study of high dose amonafide with autologous bone marrow rescue (ABMR). American Federation for Clinical Research, Midwest Section, November 1, 1990.

Ellis E, Moormeier J, Williams S, Kaminer L, Mick R, Bitran J. A phase II study of mitoxantrone, vincristine, and 5-fluorouracil with leucovorin (MVFL) as induction chemotherapy in women with stage IV breast cancer. 13th Annual San Antonio Breast Cancer Symposium, November 2-3, 1990.

Ellis E, Moormeier J, Kaminer L, Mick R, Williams S and Bitran J. A phase I-II study of high dose cyclophosphamide, thiotepa and mitoxantrone (CTM) in autologous bone marrow reinfusion (ABMR) in patients with refractory malignancies. Proceedings of ASCO, 9: 17, 1990.


  • Oncology - Medical
Clinical Interests
  • Breast Cancer
  • Genetic Counseling
  • Medical Oncologists
  • Medical Oncology
  • Practice Limited to Breast Cancer